Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Name_of_Study,Research_Information_Link,Context_of_Research
211123,"Merck Sharp & Dohme Corporation",NJ,100000000053,577.36,10/04/2013,"In-kind items and services",24448900,JANUVIA,"","TECOS A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on","",""
211123,"Merck Sharp & Dohme Corporation",NJ,100000000053,395.46,08/09/2013,"In-kind items and services",24446207,JANUVIA,"","TECOS A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on","",""
211123,"Merck Sharp & Dohme Corporation",NJ,100000000053,377.59,12/20/2013,"In-kind items and services",24448863,JANUVIA,"","TECOS A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on","",""
211123,"Merck Sharp & Dohme Corporation",NJ,100000000053,265.00,11/14/2013,"In-kind items and services",24448862,JANUVIA,"","TECOS A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on","",""
211123,"Merck Sharp & Dohme Corporation",NJ,100000000053,182.52,09/11/2013,"In-kind items and services",24446206,JANUVIA,"","TECOS A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on","",""
211123,"ELI LILLY AND COMPANY",IN,100000000088,52.00,12/31/2013,"In-kind items and services",105731344,AXIRON,"","A Randomized Double Blind Placebo Controlled Parallel Study With an Open Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone Sex Drive and Energy in Hypogonadal Men",http://clinicaltrials.gov/ct2/show/NCT01816295,""
